Vimarsana
Biggest News Aggregation in the World

Processing Deficient Progeroid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Processing Deficient Progeroid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Processing Deficient Progeroid Today - Breaking & Trending Today

First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Progeria Receives Approval in Japan - Vimarsana News

First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Progeria Receives Approval in Japan

/PRNewswire/ -- The Progeria Research Foundation (PRF) today announced a new milestone with the approval of Zokinvy™ (lonafarnib) by the Japanese Ministry of...

Eiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

Eiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

Resources prioritized to advance avexitide in hyperinsulinemic hypoglycemia indicationsActive discussions underway with potential partners to advance late-stage virology programsReduction in... -Today at 04:06 pm- MarketScreener

Eiger BioPharmaceuticals to Focus on Metabolic Diseases with Avexitide; David Apelian Takes Helm as CEO - Vimarsana News

Eiger BioPharmaceuticals to Focus on Metabolic Diseases with Avexitide; David Apelian Takes Helm as CEO

Prioritizing resources to advance avexitide in hyperinsulinemic hypoglycemia indicationsActive discussions underway with potential partners to advance late-stage virology programsReduction in workforce executed to align with focus on avexitide; ext...

Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update - Vimarsana News

Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

Eiger BioPharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update - Vimarsana News

Eiger BioPharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...